| Drug Type Small molecule drug | 
| Synonyms | 
| Target | 
| Action inhibitors | 
| Mechanism KDM1A inhibitors(Lysine-specific histone demethylase 1 inhibitors), MAO-B inhibitors(Monoamine oxidase B inhibitors) | 
| Therapeutic Areas | 
| Active Indication- | 
| Inactive Indication | 
| Originator Organization | 
| Active Organization- | 
| Inactive Organization | 
| License Organization- | 
| Drug Highest PhasePendingDiscovery | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Alzheimer Disease | Discovery | Spain  | - | |
| Parkinson Disease | Discovery | Spain  | - | 





